Anticoagulants, antiplatelets, and thrombolytics / edited by Shaker A. Mousa.
Material type: TextLanguage: English Series: Methods in molecular medicine ; 93Publication details: Totowa, N.J. : Humana Press, c2004.Description: x, 307 p. : ill. ; 24 cmISBN:- 1588290832 (alk. paper)
- 615.718 22 MOU
- W1
- QZ 170
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
General Books | CUTN Central Library Medicine, Technology & Management | Non-fiction | 615.718 MOU (Browse shelf(Opens below)) | Available | 38249 |
Highlights of latest advances in antithrombotics
Antiplatelet, anticoagulant, and thrombolytic drug interactions
Evaluation of platelet antagonists in in vitro flow models of thrombosis Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases
Are low molecular weight heparins the same? Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia
Laboratory methods for heparin-induced thrombocytopenia
Factor Xa inhibitors Tissue factor/VIIa in thrombosis and cancer Tissue factor pathway inhibitor in thrombosis and beyond Cell adhesion molecules: potential therapeutic and diagnostic implications
Development and applications of animal models of thrombosis A survey of venous thrombosis models Arixtra (fondaparinux sodium) Oral thrombin inhibitor ximelagatran Pharmacogenomics and coagulation disorders Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism
"During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and invention highlight the latest developments in antithrombotics and provide experimental methods for the discovery of new Read more...
Includes bibliographical references and index.
There are no comments on this title.